Literature DB >> 17222504

In search of tumor suppressing functions of menin.

Yuqing Yang1, Xianxin Hua.   

Abstract

Human hereditary tumor syndromes serve as an ideal model for studying molecular pathways regulating tumorigenesis. Multiple endocrine neoplasia type 1 (MEN1), a human familial tumor syndrome, results from mutations in the Men1 gene. Men1 encodes a novel tumor suppressor, menin, of unknown biochemical function. Recently, significant progress has been made in identifying menin as a regulator of gene transcription, cell proliferation, apoptosis, and genome stability, leading to a new model of understanding menin's tumor-suppressing function. These findings suggest that menin's diverse functions depend on its association with chromatin and its control over gene transcription. This knowledge will likely be translated into new strategies to improve therapeutic interventions against MEN1 and other related cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222504      PMCID: PMC1919399          DOI: 10.1016/j.mce.2006.12.032

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  69 in total

1.  Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

Authors:  I Lemmens; W J Van de Ven; K Kas; C X Zhang; S Giraud; V Wautot; N Buisson; K De Witte; J Salandre; G Lenoir; M Pugeat; A Calender; F Parente; D Quincey; P Gaudray; M J De Wit; C J Lips; J W Höppener; S Khodaei; A L Grant; G Weber; S Kytölä; B T Teh; F Farnebo; R V Thakker
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

2.  Fas ligand: a sensor for DNA damage critical in skin cancer etiology.

Authors:  L L Hill; A Ouhtit; S M Loughlin; M L Kripke; H N Ananthaswamy; L B Owen-Schaub
Journal:  Science       Date:  1999-08-06       Impact factor: 47.728

Review 3.  The gene for multiple endocrine neoplasia type 1: recent findings.

Authors:  S J Marx; S K Agarwal; C Heppner; Y S Kim; M B Kester; P K Goldsmith; M C Skarulis; A M Spiegel; A L Burns; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; M R Emmert-Buck; S C Guru; P Manickam; J S Crabtree; F S Collins; S C Chandrasekharappa
Journal:  Bone       Date:  1999-07       Impact factor: 4.398

4.  Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription.

Authors:  S K Agarwal; S C Guru; C Heppner; M R Erdos; R M Collins; S Y Park; S Saggar; S C Chandrasekharappa; F S Collins; A M Spiegel; S J Marx; A L Burns
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

5.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.

Authors:  E E Varfolomeev; M Schuchmann; V Luria; N Chiannilkulchai; J S Beckmann; I L Mett; D Rebrikov; V M Brodianski; O C Kemper; O Kollet; T Lapidot; D Soffer; T Sobe; K B Avraham; T Goncharov; H Holtmann; P Lonai; D Wallach
Journal:  Immunity       Date:  1998-08       Impact factor: 31.745

6.  Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex.

Authors:  Hyungsoo Kim; Ji-Eun Lee; Eun-Jung Cho; Jun O Liu; Hong-Duk Youn
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

7.  Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter.

Authors:  Sunita K Agarwal; Elizabeth A Novotny; Judy S Crabtree; Jonathan B Weitzman; Moshe Yaniv; A Lee Burns; Settara C Chandrasekharappa; Francis S Collins; Allen M Spiegel; Stephen J Marx
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

8.  Menin associates with FANCD2, a protein involved in repair of DNA damage.

Authors:  Shenghao Jin; Hua Mao; Robert W Schnepp; Stephen M Sykes; Albert C Silva; Alan D D'Andrea; Xianxin Hua
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

9.  Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model.

Authors:  Aaron N Cranston; Bruce A J Ponder
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

Review 10.  Carcinoid--a comprehensive review.

Authors:  Isac I Schnirer; James C Yao; Jaffer A Ajani
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

View more
  37 in total

Review 1.  Trithorax group proteins: switching genes on and keeping them active.

Authors:  Bernd Schuettengruber; Anne-Marie Martinez; Nicola Iovino; Giacomo Cavalli
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

2.  Crystal structure of menin reveals binding site for mixed lineage leukemia (MLL) protein.

Authors:  Marcelo J Murai; Maksymilian Chruszcz; Gireesh Reddy; Jolanta Grembecka; Tomasz Cierpicki
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

3.  MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair.

Authors:  Lorri R Marek; Molly C Kottemann; Peter M Glazer; Allen E Bale
Journal:  DNA Repair (Amst)       Date:  2008-02-06

4.  Menin represses tumorigenesis via repressing cell proliferation.

Authors:  Ting Wu; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-05-16       Impact factor: 6.166

Review 5.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 6.  Familial pituitary tumor syndromes.

Authors:  Marianne S Elston; Kerrie L McDonald; Roderick J Clifton-Bligh; Bruce G Robinson
Journal:  Nat Rev Endocrinol       Date:  2009-06-30       Impact factor: 43.330

Review 7.  Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.

Authors:  Xinjiang Wu; Xianxin Hua
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

8.  PTCH 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic target.

Authors:  Buddha Gurung; Xianxin Hua; Melissa Runske; Bonita Bennett; Virginia LiVolsi; Robert Roses; Douglas A Fraker; David C Metz
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

9.  Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.

Authors:  Buddha Gurung; Zijie Feng; Daniel V Iwamoto; Austin Thiel; Guanghui Jin; Chen-Min Fan; Jessica M Y Ng; Tom Curran; Xianxin Hua
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

10.  Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model.

Authors:  Molly C Kottemann; Allen E Bale
Journal:  DNA Repair (Amst)       Date:  2009-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.